Blood Pressure and Arteries STUDIES

Highlights Meta-analysis of 17 randomized, placebo-controlled clinical trials  Subjects include people with CVD, diabetes and other diseases  CoQ10 dosage ranged from 60-300 mg/day, duration from 1 week to 4 months...

Highlights Meta-analysis of 9 RCTs with over 428 adults with metabolic diseases CoQ10 supplementation reduces TNF-alpha, a key marker of inflammation Dosages range from 100 to 500 mg/day for 8-12 weeks...

Highlights Meta-analysis of 18 randomized, controlled trials with patients with metabolic syndrome and related disorders ALA supplementation ranges from 300 to 600 mg/day Study duration ranges from 2 weeks to 12 months Treatment significantly...

Highlights Meta-analysis of 24 randomized, controlled trials with patients with metabolic diseases ALA supplementation ranges from 200 to 1,800 mg/day Study duration ranges from 2 to 51 weeks ALA supplementation significantly improves glycemic...